Chemotherapy: Open Access : Citations & Metrics Report
Articles published in Chemotherapy: Open Access have been cited by esteemed scholars and scientists all around the world. Chemotherapy: Open Access has got h-index 12, which means every article in Chemotherapy: Open Access has got 12 average citations.
Following are the list of articles that have cited the articles published in Chemotherapy: Open Access.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
26 | 36 | 28 | 30 | 8 | 0 | 17 | 24 | 52 | 34 | 23 | 18 | 27 |
Research, Review articles and Editorials |
0 | 9 | 7 | 20 | 5 | 0 | 13 | 17 | 22 | 18 | 18 | 16 | 27 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
14 | 26 | 21 | 5 | 3 | 0 | 4 | 7 | 24 | 14 | 4 | 2 | 0 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
36 | 53 | 100 | 85 | 112 | 83 | 142 | 208 | 141 | 51 | 22 | 53 | 3 |
| Journal total citations count | 709 |
| Journal impact factor | 1.81 |
| Journal 5 years impact factor | 3.80 |
| Journal cite score | 4.89 |
| Journal h-index | 12 |
| Journal h-index since 2019 | 9 |
Important citations (402)
satya srinivas v. research and reviews: journal of medical and health sciences. |
|
anitha sri s, prudhvi raj p. incidence and prevalence of breast cancer in usa. biochem mol biol lett. 2017;2(1):102. |
|
alshehri af, alnatsheh a, aseeri m, al fayea t. evaluation of the use of granulocyte colony-stimulating factors (g-csfs) for neutropenia primary prophylaxis in solid tumors at a tertiary care hospital, retrospective study. j pharmacovigil. 2017;5(248):2. |
|
joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review. |
|
tripathi s, madan a. biomarkers role in breast cancer treatment-a review. |
|
rachana n. research & reviews: journal of pharmaceutics and nanotechnology. |
|
joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review. |
|
joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review. |
|
tripathi s, madan a. biomarkers role in breast cancer treatment-a review. |
|
rachana n. research & reviews: journal of pharmaceutics and nanotechnology. |
|
joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review. |
|
tripathi s, madan a. biomarkers role in breast cancer treatment-a review. |
|
bala r, sharma d, kaur a. research & reviews: journal of medical and health sciences. |
|
kamini j. why imatinib is by far the best drug to treat chronic myeloid leukemia. biochem mol biol lett. 2017;3(2):112. |
|
joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review. |
|
tripathi s, madan a. biomarkers role in breast cancer treatment-a review. |
|
joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review. |
|
joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review. |
|
tripathi s, madan a. biomarkers role in breast cancer treatment-a review. |
|
joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review. |
|